Correlation Between Pro Dex and Akoya Biosciences
Can any of the company-specific risk be diversified away by investing in both Pro Dex and Akoya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pro Dex and Akoya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pro Dex and Akoya Biosciences, you can compare the effects of market volatilities on Pro Dex and Akoya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pro Dex with a short position of Akoya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pro Dex and Akoya Biosciences.
Diversification Opportunities for Pro Dex and Akoya Biosciences
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pro and Akoya is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Pro Dex and Akoya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akoya Biosciences and Pro Dex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pro Dex are associated (or correlated) with Akoya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akoya Biosciences has no effect on the direction of Pro Dex i.e., Pro Dex and Akoya Biosciences go up and down completely randomly.
Pair Corralation between Pro Dex and Akoya Biosciences
Given the investment horizon of 90 days Pro Dex is expected to generate 1.02 times more return on investment than Akoya Biosciences. However, Pro Dex is 1.02 times more volatile than Akoya Biosciences. It trades about 0.25 of its potential returns per unit of risk. Akoya Biosciences is currently generating about 0.01 per unit of risk. If you would invest 2,210 in Pro Dex on September 4, 2024 and sell it today you would earn a total of 2,691 from holding Pro Dex or generate 121.76% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.44% |
Values | Daily Returns |
Pro Dex vs. Akoya Biosciences
Performance |
Timeline |
Pro Dex |
Akoya Biosciences |
Pro Dex and Akoya Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pro Dex and Akoya Biosciences
The main advantage of trading using opposite Pro Dex and Akoya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pro Dex position performs unexpectedly, Akoya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akoya Biosciences will offset losses from the drop in Akoya Biosciences' long position.Pro Dex vs. Coloplast A | Pro Dex vs. Straumann Holding AG | Pro Dex vs. Nephros | Pro Dex vs. InfuSystems Holdings |
Akoya Biosciences vs. AtriCure | Akoya Biosciences vs. ICU Medical | Akoya Biosciences vs. Haemonetics | Akoya Biosciences vs. AngioDynamics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |